Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Adapalene Patent Expiration

Adapalene is Used for treating acne vulgaris. It was first introduced by Galderma Laboratories Lp in its drug Differin on May 31, 1996. 10 different companies have introduced drugs containing Adapalene.


Adapalene Patents

Given below is the list of patents protecting Adapalene, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Differin US7998467 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers May 31, 2028 Galderma Labs Lp
Differin US8435502 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers Sep 15, 2026 Galderma Labs Lp
Differin US8709392 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers Sep 15, 2026 Galderma Labs Lp
Differin US7579377 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Feb 23, 2025 Galderma Labs Lp
Differin US7737181 Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Aug 29, 2024

(Expired)

 Galderma Labs Lp
Differin US7834060 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

 Galderma Labs Lp
Differin US7838558 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

 Galderma Labs Lp
Differin US7868044 Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid Mar 12, 2023

(Expired)

 Galderma Labs Lp
Differin US8703820 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

 Galderma Labs Lp



Adapalene's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Adapalene Generics

Several generic applications have been filed for Adapalene. The first generic version for Adapalene was by P And L Development Llc and was approved on Jun 2, 2010. And the latest generic version is by Taro Pharmaceuticals Inc and was approved on Jan 14, 2022.

Given below is the list of companies who have filed for Adapalene generic.


1. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.3% gel Prescription TOPICAL AB Oct 27, 2014


2. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.3% gel Prescription TOPICAL AB Jun 18, 2020


3. CALL INC

Call Inc Dba Rochester Pharmaceuticals has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Call Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% solution Prescription TOPICAL AB Sep 23, 2016


4. ENCUBE ETHICALS

Encube Ethicals Pvt Ltd has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Encube Ethicals.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.3% gel Prescription TOPICAL AB Jun 14, 2012


5. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% cream Prescription TOPICAL AB Jun 30, 2010


6. GLENMARK GENERICS

Glenmark Generics Inc Usa has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Glenmark Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% gel Over the counter TOPICAL N/A Jul 9, 2019


7. GLENMARK PHARMS INC

Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% gel Over the counter TOPICAL N/A Jul 1, 2010


8. P AND L

P And L Development Llc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by P And L.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1% gel Over the counter TOPICAL N/A Jun 2, 2010


9. TARO

Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Adapalene. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.3% gel Prescription TOPICAL AB Jun 23, 2016
0.1% gel Over the counter TOPICAL N/A Jan 14, 2022